{"id":"https://openalex.org/W4411705656","doi":"https://doi.org/10.1136/bmjopen-2024-098311","title":"Background rates of medical events of interest before and during the COVID-19 pandemic: a longitudinal cohort study using claims data","display_name":"Background rates of medical events of interest before and during the COVID-19 pandemic: a longitudinal cohort study using claims data","publication_year":2025,"publication_date":"2025-06-01","ids":{"openalex":"https://openalex.org/W4411705656","doi":"https://doi.org/10.1136/bmjopen-2024-098311","pmid":"https://pubmed.ncbi.nlm.nih.gov/40578892","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12207104"},"language":"en","primary_location":{"id":"doi:10.1136/bmjopen-2024-098311","doi":"https://doi.org/10.1136/bmjopen-2024-098311","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bmjopen-2024-098311","pdf_url":null,"source":{"id":"https://openalex.org/S79054089","display_name":"BMJ Open","issn_l":"2044-6055","issn":["2044-6055"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Open","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1136/bmjopen-2024-098311","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035176899","display_name":"Victor O. Popoola","orcid":"https://orcid.org/0000-0001-6729-1197","observed_orcids":["https://orcid.org/0000-0001-6729-1197"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Victor O Popoola","raw_affiliation_strings":["Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA","Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA Victor.Popoola@regeneron.com"],"raw_orcid":"https://orcid.org/0000-0001-6729-1197","affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA","institution_ids":["https://openalex.org/I186523950"]},{"raw_affiliation_string":"Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA Victor.Popoola@regeneron.com","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003140536","display_name":"Daniel Keebler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Keebler","raw_affiliation_strings":["Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103139445","display_name":"Michelle Skornicki","orcid":"https://orcid.org/0000-0002-2594-2569","observed_orcids":["https://orcid.org/0000-0002-2594-2569","https://orcid.org/0000-0002-1776-7107"]},"institutions":[{"id":"https://openalex.org/I4210106950","display_name":"Aetion (United States)","ror":"https://ror.org/02efksf92","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle Skornicki","raw_affiliation_strings":["Aetion Inc, New York, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aetion Inc, New York, New York, USA","institution_ids":["https://openalex.org/I4210106950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073670393","display_name":"Rachel E. Sobel","orcid":"https://orcid.org/0000-0002-4492-9562","observed_orcids":["https://orcid.org/0000-0002-4492-9562"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rachel E Sobel","raw_affiliation_strings":["Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jackie Lucia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106950","display_name":"Aetion (United States)","ror":"https://ror.org/02efksf92","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jackie Lucia","raw_affiliation_strings":["Aetion Inc, New York, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aetion Inc, New York, New York, USA","institution_ids":["https://openalex.org/I4210106950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012289437","display_name":"Alexander Breskin","orcid":"https://orcid.org/0000-0001-5568-2510","observed_orcids":["https://orcid.org/0000-0001-5568-2510"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander Breskin","raw_affiliation_strings":["Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA"],"raw_orcid":"https://orcid.org/0000-0001-5568-2510","affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083792668","display_name":"G\u00fclce Askin","orcid":"https://orcid.org/0000-0001-5126-9809","observed_orcids":["https://orcid.org/0000-0001-5126-9809"]},"institutions":[{"id":"https://openalex.org/I4210106950","display_name":"Aetion (United States)","ror":"https://ror.org/02efksf92","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gulce Askin","raw_affiliation_strings":["Aetion Inc, New York, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aetion Inc, New York, New York, USA","institution_ids":["https://openalex.org/I4210106950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077499177","display_name":"Julius O Asubonteng","orcid":"https://orcid.org/0000-0001-8991-3276","observed_orcids":["https://orcid.org/0000-0001-8991-3276"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julius Asubonteng","raw_affiliation_strings":["Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5118656588","display_name":"Clarke Patrone","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106950","display_name":"Aetion (United States)","ror":"https://ror.org/02efksf92","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Clarke Patrone","raw_affiliation_strings":["Aetion Inc, New York, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aetion Inc, New York, New York, USA","institution_ids":["https://openalex.org/I4210106950"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ping Shao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ping Shao","raw_affiliation_strings":["Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066277037","display_name":"Andrew Szendrey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106950","display_name":"Aetion (United States)","ror":"https://ror.org/02efksf92","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Szendrey","raw_affiliation_strings":["Aetion Inc, New York, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aetion Inc, New York, New York, USA","institution_ids":["https://openalex.org/I4210106950"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011455373","display_name":"Amanda M. Kong","orcid":"https://orcid.org/0000-0002-6210-4185","observed_orcids":["https://orcid.org/0000-0002-6210-4185"]},"institutions":[{"id":"https://openalex.org/I4210106950","display_name":"Aetion (United States)","ror":"https://ror.org/02efksf92","country_code":"US","type":"company","lineage":["https://openalex.org/I4210106950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amanda Kong","raw_affiliation_strings":["Aetion Inc, New York, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aetion Inc, New York, New York, USA","institution_ids":["https://openalex.org/I4210106950"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5035176899"],"corresponding_institution_ids":["https://openalex.org/I186523950"],"apc_list":{"value":1500,"currency":"GBP","value_usd":1839},"apc_paid":{"value":1500,"currency":"GBP","value_usd":1839},"fwci":0.7629,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.69465894,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"15","issue":"6","first_page":"e098311","last_page":"e098311"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.459199994802475,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.459199994802475,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.3043999969959259,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11296","display_name":"COVID-19 and healthcare impacts","score":0.1485999971628189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/background-rate","display_name":"background rate","score":0.8320000171661377},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9190000295639038},{"id":"https://openalex.org/keywords/covid-19-interventions","display_name":"COVID-19 interventions","score":0.7960000038146973},{"id":"https://openalex.org/keywords/incidence-rates","display_name":"incidence rates","score":0.6269999742507935},{"id":"https://openalex.org/keywords/myocarditis","display_name":"myocarditis","score":0.8309999704360962},{"id":"https://openalex.org/keywords/pericarditis","display_name":"pericarditis","score":0.9490000009536743},{"id":"https://openalex.org/keywords/pediatric-patients","display_name":"pediatric patients","score":0.5799999833106995},{"id":"https://openalex.org/keywords/high-risk-patients","display_name":"high-risk patients","score":0.722000002861023},{"id":"https://openalex.org/keywords/safety-signals","display_name":"safety signals","score":0.6259999871253967},{"id":"https://openalex.org/keywords/claims-data","display_name":"claims data","score":0.6439999938011169},{"id":"https://openalex.org/keywords/optum","display_name":"Optum","score":0.9860000014305115},{"id":"https://openalex.org/keywords/temporal-trends","display_name":"temporal trends","score":0.3109999895095825}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9014921188354492},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.7276186943054199},{"id":"https://openalex.org/C89623803","wikidata":"https://www.wikidata.org/wiki/Q12184","display_name":"Pandemic","level":5,"score":0.5718859434127808},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.5641071200370789},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.5392720699310303},{"id":"https://openalex.org/C27415008","wikidata":"https://www.wikidata.org/wiki/Q7256382","display_name":"Psychological intervention","level":2,"score":0.5325618982315063},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.5060722231864929},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.4674592614173889},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.45636409521102905},{"id":"https://openalex.org/C149923435","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demography","level":1,"score":0.37547367811203003},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34497618675231934},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.34105467796325684},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.13335326313972473},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.06556916236877441},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D000086402","descriptor_name":"SARS-CoV-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008137","descriptor_name":"Longitudinal Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1136/bmjopen-2024-098311","doi":"https://doi.org/10.1136/bmjopen-2024-098311","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bmjopen-2024-098311","pdf_url":null,"source":{"id":"https://openalex.org/S79054089","display_name":"BMJ Open","issn_l":"2044-6055","issn":["2044-6055"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Open","raw_type":"journal-article"},{"id":"pmid:40578892","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40578892","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ open","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:36f56e8ff1e64b4fa2bd146e49c612a6","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/36f56e8ff1e64b4fa2bd146e49c612a6","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMJ Open, Vol 15, Iss 6 (2025)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/bmjopen-2024-098311","doi":"https://doi.org/10.1136/bmjopen-2024-098311","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bmjopen-2024-098311","pdf_url":null,"source":{"id":"https://openalex.org/S79054089","display_name":"BMJ Open","issn_l":"2044-6055","issn":["2044-6055"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Open","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320311600","display_name":"Regeneron Pharmaceuticals","ror":"https://ror.org/02f51rf24"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W3012320055","https://openalex.org/W3025305522","https://openalex.org/W3032902005","https://openalex.org/W3082170884","https://openalex.org/W3134987890","https://openalex.org/W3136955306","https://openalex.org/W3166109011","https://openalex.org/W3183058561","https://openalex.org/W3202701094","https://openalex.org/W4206594482","https://openalex.org/W4206898589","https://openalex.org/W4214707898","https://openalex.org/W4224107510","https://openalex.org/W4224234802","https://openalex.org/W4224602496","https://openalex.org/W4290085573","https://openalex.org/W4292880333","https://openalex.org/W4293740214","https://openalex.org/W4296793538","https://openalex.org/W4309726397","https://openalex.org/W4311703170","https://openalex.org/W4362633643"],"related_works":["https://openalex.org/W4400598662","https://openalex.org/W4362633643","https://openalex.org/W4308461004","https://openalex.org/W3166109011","https://openalex.org/W4415564303","https://openalex.org/W4226315319","https://openalex.org/W7201042925","https://openalex.org/W3205364444","https://openalex.org/W4404225453","https://openalex.org/W3212822344"],"abstract_inverted_index":{"IMPORTANCE:":[0],"Background":[1,112],"rates":[2,22,113,132,320],"are":[3],"critical":[4],"for":[5,29,92,321],"contextualising":[6,322],"safety":[7,323],"signals":[8,324],"arising":[9],"from":[10,325],"COVID-19-related":[11,339],"interventions":[12,35],"in":[13,40,65,163,211,283,304],"investigational":[14],"or":[15],"real-world":[16],"settings.":[17],"OBJECTIVE:":[18],"To":[19],"estimate":[20],"background":[21,319],"of":[23,26,67,114,134,168,180,184,199,250,266,306,337],"medical":[24],"events":[25],"interest":[27],"(MEI)":[28],"which":[30],"COVID-19":[31,34,58,297,326],"infection":[32],"and/or":[33],"may":[36],"be":[37,331],"risk":[38,91],"factors":[39],"two":[41],"US":[42],"claims":[43],"databases.":[44],"DESIGN,":[45],"SETTING":[46],"AND":[47,128],"PARTICIPANTS:":[48],"This":[49],"retrospective":[50],"cohort":[51,76,80,85,107,177,215],"study":[52,110,176,309],"spans":[53],"the":[54,99,109,164,212,237,284,291,296,334],"pre-COVID-19":[55,292],"(2018-2019)":[56],"and":[57,70,82,152,178,191,226,274,287,314,342],"(2020-2021)":[59],"periods.":[60],"We":[61],"constructed":[62],"three":[63],"cohorts,":[64],"each":[66,106],"Inovalon/HealthVerity":[68],"(Inovalon/HV)":[69],"Optum":[71],"databases:":[72],"a":[73,78,83],"COVID-19-positive":[74,189,213,238],"adult":[75,214,239,286],"(2020-2021),":[77],"paediatric":[79,194,234,288],"(2018-2021)":[81,86],"high-risk":[84,224,285],"comprising":[87],"patients":[88,160],"at":[89],"increased":[90],"severe":[93],"COVID-19.":[94],"Participants":[95],"were":[96,117,161,186,281],"indexed":[97],"on":[98],"day":[100],"they":[101],"first":[102],"qualified":[103],"to":[104,209,221,231,259,272,333],"enter":[105],"during":[108,245,275,290,295],"period.":[111],"17":[115,135],"MEI":[116,169,185,307],"estimated":[118],"per":[119,201],"1000":[120,202],"person-years":[121],"(PY)":[122],"with":[123,278],"95%":[124],"CIs.":[125],"MAIN":[126],"OUTCOMES":[127],"MEASURES:":[129],"Annual":[130],"incidence":[131],"(IRs)":[133],"MEI.":[136],"RESULTS:":[137],"Overall,":[138],"758":[139],"414":[140],"(COVID-19-positive":[141],"adults;":[142,149],"57.8%":[143],"women),":[144],"12":[145],"513":[146],"664":[147],"(high-risk":[148],"56.8%":[150],"women)":[151,159],"8":[153],"510":[154],"627":[155],"(paediatric":[156],"patients;":[157],"49.1%":[158],"identified":[162],"HV":[165],"database.":[166],"IRs":[167,183,244,280,305],"varied":[170],"substantially":[171],"by":[172,308],"year,":[173,311],"data":[174,312,343],"source,":[175],"duration":[179],"follow-up.":[181],"The":[182],"highest":[187],"among":[188,193,223,233],"adults":[190,225],"lowest":[192],"patients.":[195,235],"For":[196],"example,":[197],"IR":[198,249,265],"myocarditis/pericarditis":[200],"PY":[203],"was":[204,302],"3.0":[205],"(95%":[206,218,228,256,269],"CI:":[207,219,229,257,270],"2.6":[208],"3.4)":[210],"vs":[216,261],"0.36":[217],"0.34":[220],"0.37)":[222],"0.05":[227,230],"0.06)":[232],"In":[236],"cohort,":[240,310],"we":[241],"observed":[242,303],"higher":[243,282],"90-day":[246],"follow-up":[247,263,315],"(eg,":[248,264],"acute":[251],"myocardial":[252],"infarction":[253],"(AMI)":[254],"26.5":[255],"25.3":[258],"27.7))":[260],"365-day":[262],"AMI":[267],"20.0":[268],"9.2":[271],"20.8))":[273],"2020":[276],"compared":[277],"2021.":[279],"populations":[289],"period":[293],"than":[294],"pandemic.":[298],"CONCLUSIONS:":[299],"Substantial":[300],"variability":[301],"source":[313],"duration.":[316],"When":[317],"generating":[318],"interventions,":[327],"careful":[328],"consideration":[329],"must":[330],"given":[332],"indicated":[335],"subpopulation":[336],"interest,":[338],"temporal":[340],"variations":[341],"sources.":[344]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2025-10-10T00:00:00"}